Blue Jet Healthcare Limited (NSE:BLUEJET)

India flag India · Delayed Price · Currency is INR
375.60
-9.70 (-2.52%)
Mar 9, 2026, 3:30 PM IST
-55.15%
Market Cap 65.15B
Revenue (ttm) 10.53B
Net Income (ttm) 2.94B
Shares Out 173.47M
EPS (ttm) 16.92
PE Ratio 22.20
Forward PE 24.08
Dividend 1.20 (0.31%)
Ex-Dividend Date Sep 19, 2025
Volume 623,648
Average Volume 1,269,775
Open 370.10
Previous Close 385.30
Day's Range 360.10 - 378.85
52-Week Range 352.55 - 1,027.80
Beta -0.35
RSI 39.90
Earnings Date May 25, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1968
Employees 196
Stock Exchange National Stock Exchange of India
Ticker Symbol BLUEJET
Full Company Profile

Financial Performance

In fiscal year 2025, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.

Financial Statements

News

There is no news available yet.